Abdellah Tebani

3.0k total citations
62 papers, 1.1k citations indexed

About

Abdellah Tebani is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Abdellah Tebani has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Physiology and 14 papers in Clinical Biochemistry. Recurrent topics in Abdellah Tebani's work include Lysosomal Storage Disorders Research (18 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Metabolism and Genetic Disorders (14 papers). Abdellah Tebani is often cited by papers focused on Lysosomal Storage Disorders Research (18 papers), Metabolomics and Mass Spectrometry Studies (14 papers) and Metabolism and Genetic Disorders (14 papers). Abdellah Tebani collaborates with scholars based in France, Sweden and United Kingdom. Abdellah Tebani's co-authors include Soumeya Bekri, Stéphane Marret, Carlos Afonso, Lénaïg Abily-Donval, Vianney Gilard, Mathias Uhlén, Isabelle Schmitz‐Afonso, Linn Fagerberg, Ivana Dabaj and Annie Laquerrière and has published in prestigious journals such as Nucleic Acids Research, Cancer Research and Scientific Reports.

In The Last Decade

Abdellah Tebani

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdellah Tebani France 20 561 261 153 151 116 62 1.1k
Michelle T. Barati United States 20 741 1.3× 122 0.5× 83 0.5× 156 1.0× 28 0.2× 52 1.5k
Jon A. Gangoiti United States 23 758 1.4× 147 0.6× 70 0.5× 298 2.0× 269 2.3× 42 1.6k
David Friedecký Czechia 21 632 1.1× 155 0.6× 52 0.3× 166 1.1× 64 0.6× 113 1.3k
Akira Imaizumi Japan 22 924 1.6× 289 1.1× 123 0.8× 80 0.5× 24 0.2× 74 1.5k
Sharad Purohit United States 23 431 0.8× 140 0.5× 279 1.8× 79 0.5× 26 0.2× 75 1.4k
Lina Nordquist Sweden 19 349 0.6× 196 0.8× 182 1.2× 105 0.7× 82 0.7× 34 1.2k
Alice Habermeier Germany 19 499 0.9× 727 2.8× 58 0.4× 105 0.7× 53 0.5× 32 1.8k
Sven Zukunft Germany 21 613 1.1× 221 0.8× 58 0.4× 56 0.4× 27 0.2× 40 1.1k
Dorothea Haas Germany 26 1.2k 2.1× 227 0.9× 183 1.2× 483 3.2× 109 0.9× 67 1.7k
Makiko Suzuki Japan 15 724 1.3× 440 1.7× 73 0.5× 72 0.5× 45 0.4× 63 1.5k

Countries citing papers authored by Abdellah Tebani

Since Specialization
Citations

This map shows the geographic impact of Abdellah Tebani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdellah Tebani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdellah Tebani more than expected).

Fields of papers citing papers by Abdellah Tebani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdellah Tebani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdellah Tebani. The network helps show where Abdellah Tebani may publish in the future.

Co-authorship network of co-authors of Abdellah Tebani

This figure shows the co-authorship network connecting the top 25 collaborators of Abdellah Tebani. A scholar is included among the top collaborators of Abdellah Tebani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdellah Tebani. Abdellah Tebani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yen, Nguyen Thi Hai, Wladimir Mauhin, Olivier Lidove, et al.. (2025). A multi-omics-empowered framework for precision diagnosis and treatment of lysosomal diseases. Journal of Pharmaceutical Analysis. 15(10). 101274–101274.
2.
Mauhin, Wladimir, Javier I. Ottaviani, Olivier Lidove, et al.. (2024). Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry. Journal of Clinical Laboratory Analysis. 39(1). e25131–e25131.
3.
Elçioğlu, Nursel, et al.. (2024). Clinical and Molecular Characterization of Mucopolysaccharidosis Type 3A and 3B in a Turkish Series. Molecular Syndromology. 15(3). 194–201. 1 indexed citations
4.
Tebani, Abdellah, Frédéric Barbey, Olivier Dormond, et al.. (2023). Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease. Translational research. 258. 47–59. 15 indexed citations
5.
Bidkhori, Gholamreza, Sunjae Lee, Abdellah Tebani, et al.. (2022). Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders. iScience. 25(7). 104513–104513. 38 indexed citations
6.
Arif, Muhammad, Cheng Zhang, Xiangyü Li, et al.. (2021). iNetModels 2.0: an interactive visualization and database of multi-omics data. Nucleic Acids Research. 49(W1). W271–W276. 29 indexed citations
7.
Gilard, Vianney, Florent Marguet, Maxime Fontanilles, et al.. (2021). Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma. Cancers. 13(20). 5157–5157. 14 indexed citations
8.
Gilard, Vianney, Stéphane Derrey, Stéphane Marret, Soumeya Bekri, & Abdellah Tebani. (2021). Precision Neurosurgery: A Path Forward. Journal of Personalized Medicine. 11(10). 1019–1019. 3 indexed citations
9.
Dabaj, Ivana, Lénaïg Abily-Donval, Axel Lebas, et al.. (2021). Next-Generation Molecular Investigations in Lysosomal Diseases: Clinical Integration of a Comprehensive Targeted Panel. Diagnostics. 11(2). 294–294. 2 indexed citations
10.
Abily-Donval, Lénaïg, Alice Goldenberg, Gajja S. Salomons, et al.. (2021). Heterogenous Clinical Landscape in a Consanguineous Malonic Aciduria Family. International Journal of Molecular Sciences. 22(23). 12633–12633. 5 indexed citations
11.
Gilard, Vianney, Abdellah Tebani, Ivana Dabaj, et al.. (2021). Diagnosis and Management of Glioblastoma: A Comprehensive Perspective. Journal of Personalized Medicine. 11(4). 258–258. 45 indexed citations
12.
Mauhin, Wladimir, Agnès Boullier, Tony Pereira, et al.. (2021). Parsing Fabry Disease Metabolic Plasticity Using Metabolomics. Journal of Personalized Medicine. 11(9). 898–898. 11 indexed citations
13.
Legendre, Marine, et al.. (2021). An Atypical Case of Congenital Erythropoietic Porphyria. Genes. 12(11). 1828–1828. 1 indexed citations
14.
Guyant‐Maréchal, Lucie, et al.. (2021). An Atypical Case of Head Tremor and Extensive White Matter in an Adult Female Caused by 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency. Diagnostics. 11(9). 1561–1561. 1 indexed citations
15.
Dabaj, Ivana, François Lecoquierre, Kimiyo Raymond, et al.. (2021). NGLY1 Deficiency: A Rare Newly Described Condition with a Typical Presentation. Life. 11(3). 187–187. 14 indexed citations
16.
Gilard, Vianney, Abdellah Tebani, Soumeya Bekri, & Stéphane Marret. (2020). Intraventricular Hemorrhage in Very Preterm Infants: A Comprehensive Review. Journal of Clinical Medicine. 9(8). 2447–2447. 51 indexed citations
17.
Tebani, Abdellah, Wladimir Mauhin, Lénaïg Abily-Donval, et al.. (2020). A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease. Journal of Clinical Medicine. 9(5). 1325–1325. 32 indexed citations
18.
Gummesson, Anders, Elias Björnson, Linn Fagerberg, et al.. (2020). Longitudinal plasma protein profiling of newly diagnosed type 2 diabetes. EBioMedicine. 63. 103147–103147. 18 indexed citations
19.
Marguet, Florent, Annie Laquerrière, Stéphane Marret, et al.. (2019). A new optimization strategy for MALDI FTICR MS tissue analysis for untargeted metabolomics using experimental design and data modeling. Analytical and Bioanalytical Chemistry. 411(17). 3891–3903. 12 indexed citations
20.
Tebani, Abdellah, Isabelle Schmitz‐Afonso, Lénaïg Abily-Donval, et al.. (2017). Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling. Clinica Chimica Acta. 475. 7–14. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle T. Barati Breakdown of academic impact, for papers by Jon A. Gangoiti Breakdown of academic impact, for papers by David Friedecký Breakdown of academic impact, for papers by Akira Imaizumi Breakdown of academic impact, for papers by Sharad Purohit Breakdown of academic impact, for papers by Lina Nordquist Breakdown of academic impact, for papers by Alice Habermeier Breakdown of academic impact, for papers by Sven Zukunft Breakdown of academic impact, for papers by Dorothea Haas Breakdown of academic impact, for papers by Makiko Suzuki
Rankless by CCL
2026